53 related articles for article (PubMed ID: 10597306)
1. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein.
Sjöblom T; Boureux A; Rönnstrand L; Heldin CH; Ghysdael J; Ostman A
Oncogene; 1999 Nov; 18(50):7055-62. PubMed ID: 10597306
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13).
Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K
Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641
[TBL] [Abstract][Full Text] [Related]
3. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
4. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.
Carroll M; Tomasson MH; Barker GF; Golub TR; Gilliland DG
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14845-50. PubMed ID: 8962143
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity to imatinib but low frequency of the TEL/PDGFRbeta fusion protein in chronic myelomonocytic leukemia.
Gunby RH; Cazzaniga G; Tassi E; Le Coutre P; Pogliani E; Specchia G; Biondi A; Gambacorti-Passerini C
Haematologica; 2003 Apr; 88(4):408-15. PubMed ID: 12681968
[TBL] [Abstract][Full Text] [Related]
6. TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle.
Dierov J; Xu Q; Dierova R; Carroll M
Blood; 2002 Mar; 99(5):1758-65. PubMed ID: 11861293
[TBL] [Abstract][Full Text] [Related]
7. TEL/JAK2 tyrosine kinase inhibits DNA repair in the presence of amifostine.
Gloc E; Warszawski M; Młynarski W; Stolarska M; Hoser G; Skorski T; Błasiak J
Acta Biochim Pol; 2002; 49(1):121-8. PubMed ID: 12136932
[TBL] [Abstract][Full Text] [Related]
8. The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways.
Sternberg DW; Tomasson MH; Carroll M; Curley DP; Barker G; Caprio M; Wilbanks A; Kazlauskas A; Gilliland DG
Blood; 2001 Dec; 98(12):3390-7. PubMed ID: 11719379
[TBL] [Abstract][Full Text] [Related]
9. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
[TBL] [Abstract][Full Text] [Related]
10. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1).
Horn S; Meyer J; Stocking C; Ostertag W; Jücker M
Oncogene; 2003 Oct; 22(46):7170-80. PubMed ID: 14562045
[TBL] [Abstract][Full Text] [Related]
11. [The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].
Zuna J
Cas Lek Cesk; 2001 Mar; 140(5):131-7. PubMed ID: 11347199
[TBL] [Abstract][Full Text] [Related]
12. THOC5 spliceosome protein: a target for leukaemogenic tyrosine kinases that affects inositol lipid turnover.
Pierce A; Carney L; Hamza HG; Griffiths JR; Zhang L; Whetton BA; Gonzalez Sanchez MB; Tamura T; Sternberg D; Whetton AD
Br J Haematol; 2008 May; 141(5):641-50. PubMed ID: 18373705
[TBL] [Abstract][Full Text] [Related]
13. Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation.
Chen J; Williams IR; Kutok JL; Duclos N; Anastasiadou E; Masters SC; Fu H; Gilliland DG
Blood; 2004 Jul; 104(2):535-42. PubMed ID: 15054045
[TBL] [Abstract][Full Text] [Related]
14. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.
Magnusson MK; Meade KE; Brown KE; Arthur DC; Krueger LA; Barrett AJ; Dunbar CE
Blood; 2001 Oct; 98(8):2518-25. PubMed ID: 11588050
[TBL] [Abstract][Full Text] [Related]
15. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
[TBL] [Abstract][Full Text] [Related]
16. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
[TBL] [Abstract][Full Text] [Related]
17. The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors.
Okuda K; Sato Y; Sonoda Y; Griffin JD
Int J Hematol; 2004 Feb; 79(2):138-46. PubMed ID: 15005341
[TBL] [Abstract][Full Text] [Related]
18. RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation.
Ballerini P; Struski S; Cresson C; Prade N; Toujani S; Deswarte C; Dobbelstein S; Petit A; Lapillonne H; Gautier EF; Demur C; Lippert E; Pages P; Mansat-De Mas V; Donadieu J; Huguet F; Dastugue N; Broccardo C; Perot C; Delabesse E
Leukemia; 2012 Nov; 26(11):2384-9. PubMed ID: 22513837
[TBL] [Abstract][Full Text] [Related]
19. The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor β (Tel-PdgfRβ) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).
Huang W; Hu L; Bei L; Hjort E; Eklund EA
J Biol Chem; 2012 Mar; 287(11):8110-25. PubMed ID: 22262849
[TBL] [Abstract][Full Text] [Related]
20. Complete remission of TEL-PDGFRB-induced myeloproliferative disease in mice by receptor tyrosine kinase inhibitor SU11657.
Cain JA; Grisolano JL; Laird AD; Tomasson MH
Blood; 2004 Jul; 104(2):561-4. PubMed ID: 15044254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
